Taiwan News
EDITORIAL
Date: 2016-03-03
By: Taiwan News, Staff Writer
President-elect Tsai Ing-wen is not scheduled to be sworn in and become Taiwan’s 
first-ever female president until May 20, but already her relatives have come under scrutiny and their business dealings analyzed.
She started a tour of Taiwan’s economic sectors with biotechnology, one of the most promising industries likely to lift the country out of its present gloom and on to a higher plane of development.
Yet, just days later, accusations surfaced of insider trading at one of the most prominent companies in the sector, OBI Pharma Inc. The plot thickened even further when reports in the media identified Tsai Ying-yang, one of the president-elect’s brothers, as a shareholder in OBI Pharma.
While there was not a single report indicating he was involved in the as yet unproven case of insider trading, fingers immediately started pointing at Tsai, saying she was no better than the average Kuomintang politician.
She made the right response to the accusations, announcing she would resolve any likely conflicts of interest before her May 20 inauguration. She also denied any knowledge of her brother’s business activities. [FULL STORY]
